ERBB2 and ovarian carcinoma: Amplification of the HER2/neu gene and/or overexpression of the corresponding protein have been identified in invasive breast, non-small cell lung, and ovarian carcinomas as well as B-cell acute lymphoblastic leukemia [1], [2].